001037540 001__ 1037540
001037540 005__ 20250313202504.0
001037540 0247_ $$2doi$$a10.1016/j.ejmech.2025.117265
001037540 0247_ $$2ISSN$$a0009-4374
001037540 0247_ $$2ISSN$$a0223-5234
001037540 0247_ $$2ISSN$$a1768-3254
001037540 0247_ $$2datacite_doi$$a10.34734/FZJ-2025-00729
001037540 0247_ $$2pmid$$a39826488
001037540 0247_ $$2WOS$$aWOS:001404938800001
001037540 037__ $$aFZJ-2025-00729
001037540 041__ $$aEnglish
001037540 082__ $$a610
001037540 1001_ $$0P:(DE-Juel1)180770$$aHoffmann, Chris$$b0$$ufzj
001037540 245__ $$a[18F]R91150: Improved radiosynthesis and in vivo evaluation as imaging probe for 5-HT2A receptors
001037540 260__ $$aAmsterdam [u.a.]$$bElsevier Science$$c2025
001037540 3367_ $$2DRIVER$$aarticle
001037540 3367_ $$2DataCite$$aOutput Types/Journal article
001037540 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1737463451_14659
001037540 3367_ $$2BibTeX$$aARTICLE
001037540 3367_ $$2ORCID$$aJOURNAL_ARTICLE
001037540 3367_ $$00$$2EndNote$$aJournal Article
001037540 500__ $$aThis work was supported by Deutsche Forschungsgemeinschaft (DFG) grants ZL 65/1-1, ZL 65/3-1 and ZL 65/4-1.
001037540 520__ $$aSerotonergic 5-HT2A receptors in the cortex and other forebrain structures have been linked to cognitive,emotional and memory processes. In addition, dysfunction or altered expression of these receptors is associatedwith neuropsychiatric and neurodegenerative disorders. [18F]R91150 is a candidate radiotracer for positronemission tomography (PET) imaging of 5-HT2A receptors, which showed promising properties in in vitro studies.However, existing methods for the production of [18F]R91150 are rather inefficient and its imaging propertieshave not been studied in vivo. In the present work, we describe improved protocols for preparation of[18F]R91150, the corresponding reference compound and two alternative boronate radiolabeling precursors.Furthermore, we present the results of an in vivo evaluation of the radioligand in rodents. [18F]R91150 wasprepared in activity yields of 20 ± 5% (two-step radiosynthesis) or 12 ± 2% (one-step radiosynthesis) and withmolar activities of >200 GBq/μmol. μPET measurements in mice revealed sufficient stability against in vivodefluorination and predominantly hepatobiliary excretion of the tracer, with high radioactivity uptake in gallbladder and intestines. μPET imaging in rats demonstrated specific tracer accumulation in the cortex andsubcortical forebrain structures, which could be reduced by pretreatment or displacement with the 5-HT2A receptorligands altanserin or ketanserin but was insensitive to pretreatment with the 5-HT2C receptor ligandSB242084. In addition, [18F]R91150 showed specific accumulation in the choroid plexus that was much lesssensitive to displacement with ketanserin and unaffected by pretreatment with altanserin or SB242084. Takentogether, our results indicate that [18F]R91150 may be a promising candidate for in vivo PET imaging of cortical5-HT2A receptors, although further studies will be required to elucidate the mechanisms underlying traceraccumulation in the choroid plexus.
001037540 536__ $$0G:(DE-HGF)POF4-5253$$a5253 - Neuroimaging (POF4-525)$$cPOF4-525$$fPOF IV$$x0
001037540 588__ $$aDataset connected to CrossRef, Journals: juser.fz-juelich.de
001037540 7001_ $$0P:(DE-Juel1)180330$$aEndepols, Heike$$b1$$ufzj
001037540 7001_ $$0P:(DE-Juel1)176705$$aUrusova, Elizaveta$$b2$$ufzj
001037540 7001_ $$0P:(DE-HGF)0$$aElchine, Dominik$$b3
001037540 7001_ $$0P:(DE-Juel1)175142$$aNeumaier, Felix$$b4$$ufzj
001037540 7001_ $$0P:(DE-Juel1)166419$$aNeumaier, Bernd$$b5$$eCorresponding author$$ufzj
001037540 7001_ $$0P:(DE-Juel1)185610$$aZlatopolskiy, Boris$$b6$$ufzj
001037540 773__ $$0PERI:(DE-600)2005170-0$$a10.1016/j.ejmech.2025.117265$$gVol. 286, p. 117265 -$$p117265$$tEuropean journal of medicinal chemistry$$v286$$x0009-4374$$y2025
001037540 8564_ $$uhttps://juser.fz-juelich.de/record/1037540/files/%5B18F%5DR91150%3A%20Improved%20radiosynthesis%20and%20in%20vivo%20evaluation%20as%20imaging%20probe%20for%205-HT2A%20receptors.pdf$$yOpenAccess
001037540 8767_ $$d2025-03-13$$eHybrid-OA$$jDEAL
001037540 909CO $$ooai:juser.fz-juelich.de:1037540$$pVDB$$pdriver$$pOpenAPC_DEAL$$popen_access$$popenaire$$popenCost$$pdnbdelivery
001037540 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)180770$$aForschungszentrum Jülich$$b0$$kFZJ
001037540 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)180330$$aForschungszentrum Jülich$$b1$$kFZJ
001037540 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)176705$$aForschungszentrum Jülich$$b2$$kFZJ
001037540 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)175142$$aForschungszentrum Jülich$$b4$$kFZJ
001037540 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)166419$$aForschungszentrum Jülich$$b5$$kFZJ
001037540 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)185610$$aForschungszentrum Jülich$$b6$$kFZJ
001037540 9131_ $$0G:(DE-HGF)POF4-525$$1G:(DE-HGF)POF4-520$$2G:(DE-HGF)POF4-500$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$9G:(DE-HGF)POF4-5253$$aDE-HGF$$bKey Technologies$$lNatural, Artificial and Cognitive Information Processing$$vDecoding Brain Organization and Dysfunction$$x0
001037540 9141_ $$y2025
001037540 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2025-01-07
001037540 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2025-01-07
001037540 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2025-01-07
001037540 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2025-01-07
001037540 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2025-01-07
001037540 915__ $$0StatID:(DE-HGF)1200$$2StatID$$aDBCoverage$$bChemical Reactions$$d2025-01-07
001037540 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bEUR J MED CHEM : 2022$$d2025-01-07
001037540 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2025-01-07
001037540 915__ $$0StatID:(DE-HGF)1210$$2StatID$$aDBCoverage$$bIndex Chemicus$$d2025-01-07
001037540 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2025-01-07
001037540 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2025-01-07
001037540 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
001037540 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2025-01-07
001037540 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bEUR J MED CHEM : 2022$$d2025-01-07
001037540 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2025-01-07
001037540 915__ $$0LIC:(DE-HGF)CCBY4$$2HGFVOC$$aCreative Commons Attribution CC BY 4.0
001037540 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz$$d2025-01-07$$wger
001037540 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2025-01-07
001037540 915pc $$0PC:(DE-HGF)0000$$2APC$$aAPC keys set
001037540 915pc $$0PC:(DE-HGF)0001$$2APC$$aLocal Funding
001037540 915pc $$0PC:(DE-HGF)0002$$2APC$$aDFG OA Publikationskosten
001037540 915pc $$0PC:(DE-HGF)0125$$2APC$$aDEAL: Elsevier 09/01/2023
001037540 920__ $$lyes
001037540 9201_ $$0I:(DE-Juel1)INM-5-20090406$$kINM-5$$lNuklearchemie$$x0
001037540 9801_ $$aFullTexts
001037540 980__ $$ajournal
001037540 980__ $$aVDB
001037540 980__ $$aUNRESTRICTED
001037540 980__ $$aI:(DE-Juel1)INM-5-20090406
001037540 980__ $$aAPC